Cytokine levels in various intravenous immunoglobulin (IVIg) preparations

Human Antibodies

Volumn 10, Issue 2, 2001, Pages 51-53

  Sherer, Yaniv ^a   Wu, Ruihua ^b   Krause, Ilan ^a   Gorstein, Alexander ^a   Levy, Yair ^a   Peter, James B ^b   Shoenfeld, Yehuda ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Specialty Laboratories   (United States)

Author keywords

Autoantibody; Autoimmunity; Cytokine; Interleukin; Intravenous immunoglobulin

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; BETA INTERFERON; CYTOKINE; IMMUNOGLOBULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; DRUG BLOOD LEVEL; DRUG MECHANISM; ENZYME IMMUNOASSAY; HUMAN; IMMUNOMODULATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0034774983     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2001-10201     Document Type: Article

References (13)

1. IL-2, IL-6 and TNF levels in primary antiphospholipid syndrome
2. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages
3. High dose intravenous immunoglobulin (IVIG) in dermatomyositis: Clinical responses and effect on sIL-2R levels
4. A study of 20 SLE patients with intravenous immunoglobulin - Clinical and serologic response
5. A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG). F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation
6. Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease
7. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)
8. High dose intravenous immunoglobulins: A new step in the treatment of systemic lupus erythematosus
9. Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus
10. Blockade of proliferation and tumor necrosis factor-alpha production occurring during mixed lymphocyte reaction by interferon-gamma-specific natural antibodies contained in intravenous immunoglobulins
11. Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1 alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations
12. Interleukin-2 abnormalities in systemic lupus erythematosus and rheumatoid arthritis: A role for overproduction of interleukin-2 in hunlan autoimmunity?